Your New Fundraising Playbook
In the Ophthalmic Deals Report, Market Scope analyzes recent investments in ophthalmology and introduce companies of all stages to a network of nearly 500 potential investors and their ophthalmic investment history, enabling them to raise capital and take ophthalmic ventures to the next level.
These quarterly subscription-based reports cover recent investments in ophthalmic ventures, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings.
These are designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.
Transactions raised are categorized by fund use, including new ventures, commercial equity, sale of companies, and license payments. Four investment types are analyzed in this report: strategic investors, venture capital, public offerings, and private equity.
A detailed transaction analysis is provided for seven ophthalmic sectors: dry eye, retina, glaucoma, cataract, diagnostic, cornea, and refractive. Key investors and transactions in each sector are included. Deal counts and transaction totals are included for each ophthalmic sector.
No results
Not seeing what you need?
In addition to our standard comprehensive reports, we also leverage our expert knowledge of the ophthalmic industry to design custom research that enhances strategy and operations for our clients. Our unique experience makes us a trusted partner in defining problems and executing solutions.
Common project types include custom data analysis, surveying and/or interviewing of ophthalmologists, focus groups, territory analyses, and other primary research initiatives -- but each project is custom designed to meet each specific clients' needs.
Please contact us for an individualized project consultation.
Want to Purchase the Full Report?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.